Inflammation News and Research

RSS

New mRNA adjuvant dramatically boosts T-cell vaccine responses in mice

MIT engineers have developed a new way to amplify the T-cell response to mRNA vaccines - an advance that could lead to much more powerful cancer vaccines and stronger protection against infectious diseases.

13 May 2026

Immune-regulating molecule may offer new treatment approach for IBD patients

Mayo Clinic researchers have identified an immune-regulating molecule that may help explain why some patients with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, do not respond to commonly used therapies.

13 May 2026

Gut microbes may reveal why diabetes raises heart disease risk

Integrated gut microbiome and plasma metabolomics profiling identified distinct microbial and metabolic signatures in people with T2DM and T2DM-CAD. In a small exploratory cohort, Bacteroides sp._CAG_875 and 12-ketoLCA emerged as candidate markers that may help distinguish diabetic patients with coronary complications, pending larger validation.

13 May 2026

Rhein protects against intestinal injury in severe acute pancreatitis

Severe acute pancreatitis (SAP) remains one of the most formidable challenges in gastrointestinal emergency medicine.

13 May 2026

Icing injuries may delay healing and prolong pain recovery

Icing a sprained ankle or sore muscle, long used to reduce pain and swelling, may in the longer run delay recovery and prolong pain, new research suggests.

13 May 2026

Selective eating in autism linked to inflammatory gut bacteria

Eating habits shape gut bacteria in children with autism, with potential dietary interventions offering hope for improving gut health and inflammation.

13 May 2026

Endometriosis increases risk of some birth defects in infants

Research indicates women with endometriosis may face a higher risk of congenital anomalies in infants, emphasizing the need for further investigation.

13 May 2026

Disrupted circadian rhythms may accelerate dementia-related brain inflammation

Alzheimer's disease and other dementias impact approximately 55 million people worldwide, including 7.2 million cases in the United States alone.

13 May 2026

Tracking the aging process across tens of millions of individual cells

While much is mysterious about the aging process, change over time remains its cornerstone. The biological shifts that accompany aging seemingly occur in many cells in the body.

13 May 2026

Maternal workplace exposures may increase autism risk in children

Mothers who work in jobs where they are frequently exposed to toxic chemicals or experience high stress have higher odds of having a child with autism spectrum disorder (ASD), suggest the findings of original research published online in the journal Occupational & Environmental Medicine.

12 May 2026

Dual-pathway protein degradation approach could improve cancer treatment

Targeted protein degradation has become one of the most promising strategies in modern drug discovery, enabling scientists to eliminate disease-causing proteins instead of merely blocking them.

12 May 2026

Enterprise Therapeutics achieves primary efficacy outcome in Phase 2 clinical trial for cystic fibrosis with novel inhaled ENaC blocker ETD001

Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of people with respiratory diseases, today announced that its Phase 2 trial for ETD001, the Company's lead candidate for treatment of cystic fibrosis (CF), achieved its primary efficacy outcome.

From Enterprise Therapeutics Ltd 12 May 2026

Common tuberculosis screening test could predict long-term patient survival

Scientists have long known that the immune system plays a key role in aging. As people age, they have weaker responses to vaccination, greater risks of infection and higher levels of inflammation.

11 May 2026

Gene mapping highlights strong immune and brain connections in depression

Neurons and white blood cells differ greatly in shape, function, and location within the body. However, researchers at the University of São Paulo (USP) in Brazil discovered that certain genes are equally dysregulated in both cell types in people with depression.

11 May 2026

New AI chip identifies meibomian gland dysfunction within milliseconds

A research team from Peking Union Medical College Hospital and Tsinghua University has developed a compact optical AI chip that can identify meibomian gland dysfunction (MGD)-a major cause of dry eye disease-with more than 96% accuracy by analyzing the tissue's spectral signatures.

11 May 2026

Regular arts engagement may help slow biological aging process

Regularly taking part in arts activities such as reading, listening to music or visiting a gallery or museum may slow the pace of biological aging, suggests a new study by University College London (UCL) researchers.

11 May 2026

New CRISPR RNA scissors specifically target and destroy hepatitis E virus

An enzymatic scissors recognizes and cuts viral RNA, but leaves the host cell unharmed. This opens up new antiviral strategies against hepatitis E.

11 May 2026

Shaping the future of asthma management with the NObreath® at ATS 2026

World leaders in breath analysis Bedfont® Scientific Ltd. are pleased to be attending this years American Thoracic Society (ATS) International Conference, to exhibit the innovative NObreath® Fractional exhaled Nitric Oxide (FeNO) device at booth 1236 alongside its US distributor coVita™.

From Bedfont® Scientific Ltd 11 May 2026

Scientists discover immune cell control switch to destroy fungal infections

Scientists at the University of East Anglia (UK) have contributed to discovering a "control switch" inside our immune cells that helps the body destroy dangerous fungal infections.

11 May 2026

Urges for cardiologists to screen patients for UPF intake

The European Society of Cardiology identifies ultra-processed foods as a key cardiovascular risk, urging a shift in dietary guidelines for better heart health.

11 May 2026